Annual CFO:
-$81.22M-$8.21M(-11.24%)Summary
- As of today, TSHA annual cash from operations is -$81.22 million, with the most recent change of -$8.21 million (-11.24%) on December 31, 2024.
- During the last 3 years, TSHA annual cash from operations has risen by +$35.82 million (+30.60%).
Performance
TSHA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$24.17M-$3.98M(-19.74%)Summary
- As of today, TSHA quarterly cash from operations is -$24.17 million, with the most recent change of -$3.98 million (-19.74%) on September 30, 2025.
- Over the past year, TSHA quarterly cash from operations has dropped by -$2.55 million (-11.80%).
- TSHA quarterly cash from operations is now -264.26% below its all-time high of $14.71 million, reached on December 31, 2022.
Performance
TSHA Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$84.66M-$2.55M(-3.11%)Summary
- As of today, TSHA TTM cash from operations is -$84.66 million, with the most recent change of -$2.55 million (-3.11%) on September 30, 2025.
- Over the past year, TSHA TTM cash from operations has dropped by -$5.61 million (-7.09%).
- TSHA TTM cash from operations is now -4882.81% below its all-time high of -$1.70 million, reached on March 31, 2020.
Performance
TSHA TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
TSHA Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -11.2% | -11.8% | -7.1% |
| 3Y3 Years | +30.6% | +16.1% | +41.0% |
| 5Y5 Years | -100.0% | - | - |
TSHA Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -11.2% | +30.6% | -264.3% | +16.1% | -100.7% | +41.0% |
| 5Y | 5-Year | >-9999.0% | +30.6% | -264.3% | +41.0% | -294.0% | +42.2% |
| All-Time | All-Time | >-9999.0% | +30.6% | -264.3% | +41.0% | -4882.8% | +42.2% |
TSHA Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$24.17M(-19.7%) | -$84.66M(-3.1%) |
| Jun 2025 | - | -$20.18M(+8.3%) | -$82.11M(+1.6%) |
| Mar 2025 | - | -$22.02M(-20.4%) | -$83.43M(-2.7%) |
| Dec 2024 | -$81.22M(-11.2%) | -$18.29M(+15.4%) | -$81.22M(-2.7%) |
| Sep 2024 | - | -$21.61M(-0.5%) | -$79.05M(-4.9%) |
| Jun 2024 | - | -$21.50M(-8.5%) | -$75.39M(-3.8%) |
| Mar 2024 | - | -$19.82M(-23.0%) | -$72.65M(+0.5%) |
| Dec 2023 | -$73.02M(+17.4%) | -$16.12M(+10.2%) | -$73.02M(-73.1%) |
| Sep 2023 | - | -$17.95M(+4.4%) | -$42.19M(+20.5%) |
| Jun 2023 | - | -$18.77M(+7.0%) | -$53.05M(+21.6%) |
| Mar 2023 | - | -$20.18M(-237.2%) | -$67.64M(+23.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$88.39M(+24.5%) | $14.71M(+151.1%) | -$88.39M(+38.3%) |
| Sep 2022 | - | -$28.81M(+13.6%) | -$143.36M(+2.1%) |
| Jun 2022 | - | -$33.35M(+18.5%) | -$146.48M(-7.8%) |
| Mar 2022 | - | -$40.94M(-1.7%) | -$135.95M(-16.2%) |
| Dec 2021 | -$117.04M(-280.9%) | -$40.26M(-26.1%) | -$117.04M(-21.2%) |
| Sep 2021 | - | -$31.93M(-40.0%) | -$96.57M(-49.4%) |
| Jun 2021 | - | -$22.82M(-3.5%) | -$64.64M(-54.6%) |
| Mar 2021 | - | -$22.04M(-11.4%) | -$41.82M(-94.6%) |
| Dec 2020 | -$30.73M(>-9900.0%) | - | - |
| Dec 2020 | - | -$19.79M(-1064.7%) | -$21.49M(-1164.7%) |
| Mar 2020 | - | -$1.70M | -$1.70M |
| Dec 2019 | $0.00 | - | - |
FAQ
- What is Taysha Gene Therapies, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Taysha Gene Therapies, Inc.?
- What is Taysha Gene Therapies, Inc. annual cash from operations year-on-year change?
- What is Taysha Gene Therapies, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Taysha Gene Therapies, Inc.?
- What is Taysha Gene Therapies, Inc. quarterly cash from operations year-on-year change?
- What is Taysha Gene Therapies, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Taysha Gene Therapies, Inc.?
- What is Taysha Gene Therapies, Inc. TTM cash from operations year-on-year change?
What is Taysha Gene Therapies, Inc. annual cash from operations?
The current annual cash from operations of TSHA is -$81.22M
What is the all-time high annual cash from operations for Taysha Gene Therapies, Inc.?
Taysha Gene Therapies, Inc. all-time high annual cash from operations is $0.00
What is Taysha Gene Therapies, Inc. annual cash from operations year-on-year change?
Over the past year, TSHA annual cash from operations has changed by -$8.21M (-11.24%)
What is Taysha Gene Therapies, Inc. quarterly cash from operations?
The current quarterly cash from operations of TSHA is -$24.17M
What is the all-time high quarterly cash from operations for Taysha Gene Therapies, Inc.?
Taysha Gene Therapies, Inc. all-time high quarterly cash from operations is $14.71M
What is Taysha Gene Therapies, Inc. quarterly cash from operations year-on-year change?
Over the past year, TSHA quarterly cash from operations has changed by -$2.55M (-11.80%)
What is Taysha Gene Therapies, Inc. TTM cash from operations?
The current TTM cash from operations of TSHA is -$84.66M
What is the all-time high TTM cash from operations for Taysha Gene Therapies, Inc.?
Taysha Gene Therapies, Inc. all-time high TTM cash from operations is -$1.70M
What is Taysha Gene Therapies, Inc. TTM cash from operations year-on-year change?
Over the past year, TSHA TTM cash from operations has changed by -$5.61M (-7.09%)